WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Sunny (Shweta) Kumar
Associate
Corporate
San Francisco
sunny.kumar@wsgr.com

D415-947-2117

Download vCard
Open PDF

Sunny Kumar is a corporate associate at Wilson Sonsini Goodrich & Rosati who advises emerging and high-growth companies. She provides strategic counseling to help clients navigate complex transactions and anticipate future business and legal needs.

Sunny has extensive experience representing clients in all types of corporate matters, including formation, financing and strategic transactions, equity incentives, and corporate governance. She also represents leading venture capital firms, accelerators, and corporate strategic investment arms in a wide variety of transactions.

In addition to English, Sunny is fluent in Hindi.

Experience

Sunny Kumar is a corporate associate at Wilson Sonsini Goodrich & Rosati who advises emerging and high-growth companies. She provides strategic counseling to help clients navigate complex transactions and anticipate future business and legal needs.

Sunny has extensive experience representing clients in all types of corporate matters, including formation, financing and strategic transactions, equity incentives, and corporate governance. She also represents leading venture capital firms, accelerators, and corporate strategic investment arms in a wide variety of transactions.

In addition to English, Sunny is fluent in Hindi.

Education
  • J.D., UC Berkeley School of Law, 2016
  • B.A., Political Science, University of California, Berkeley, 2013With Highest Honors
Admissions
  • State Bar of California
Credentials
Education
  • J.D., UC Berkeley School of Law, 2016
  • B.A., Political Science, University of California, Berkeley, 2013With Highest Honors
Admissions
  • State Bar of California

Select Matters

Select company representations include:

  • Tekion in its $200 million growth capital investment from Dragoneer Investment Group*
  • Impulse Space in its $150 million Series B financing from Founders Fund*
  • Foodsmart in its $200 million Series D financing from TPG Rise Fund*
  • Twelve Labs in its $50 million Series A financing from NEA and NVIDIA and $30 million SAFE financing from various strategic investors including Databricks, SK Telecom, Snowflake, HubSpot Ventures, and IQT (In-Q-Tel)*
  • Devoted Health in its $287 million Series E financing led by The Space in Between, Highbury Holdings, GIC, Stardust Equity, Maverick Ventures, and Fearless Ventures and $1.15 billion Series D financing led by Uprising and SoftBank Vision Fund 2*
  • Versa Networks in its $120 million financing led by BlackRock*
  • Halborn in its $90 million Series A financing led by Summit Partners*
  • Lyra Health in its $235 million Series G financing led by Dragoneer*
  • Folx Health in its $30 million Series B financing*
  • Tala in its $145 million Series E financing led by Upstart*
  • Apna Time in its $100 million Series B-1 financing*
  • Gupshup in its $100 million initial Series F financing, $240 million follow-on Series F financing, and tender offer*

Select investor representations include:

  • Define Ventures in its various investments in early-stage digital healthcare companies*
  • Notable Capital in its $17 million Series A investment in Patronus AI*
  • Notable Capital in its $20 million Series A investment in Token Security*
  • Coinbase Ventures in various early-stage financing and commercial transactions*
  • Future Back Ventures in its various early-stage investments in companies founded or led by Bain & Company alumni*

*Denotes experience prior to joining Wilson Sonsini.

Matters

Select Matters

Select company representations include:

  • Tekion in its $200 million growth capital investment from Dragoneer Investment Group*
  • Impulse Space in its $150 million Series B financing from Founders Fund*
  • Foodsmart in its $200 million Series D financing from TPG Rise Fund*
  • Twelve Labs in its $50 million Series A financing from NEA and NVIDIA and $30 million SAFE financing from various strategic investors including Databricks, SK Telecom, Snowflake, HubSpot Ventures, and IQT (In-Q-Tel)*
  • Devoted Health in its $287 million Series E financing led by The Space in Between, Highbury Holdings, GIC, Stardust Equity, Maverick Ventures, and Fearless Ventures and $1.15 billion Series D financing led by Uprising and SoftBank Vision Fund 2*
  • Versa Networks in its $120 million financing led by BlackRock*
  • Halborn in its $90 million Series A financing led by Summit Partners*
  • Lyra Health in its $235 million Series G financing led by Dragoneer*
  • Folx Health in its $30 million Series B financing*
  • Tala in its $145 million Series E financing led by Upstart*
  • Apna Time in its $100 million Series B-1 financing*
  • Gupshup in its $100 million initial Series F financing, $240 million follow-on Series F financing, and tender offer*

Select investor representations include:

  • Define Ventures in its various investments in early-stage digital healthcare companies*
  • Notable Capital in its $17 million Series A investment in Patronus AI*
  • Notable Capital in its $20 million Series A investment in Token Security*
  • Coinbase Ventures in various early-stage financing and commercial transactions*
  • Future Back Ventures in its various early-stage investments in companies founded or led by Bain & Company alumni*

*Denotes experience prior to joining Wilson Sonsini.

Focus Areas
  • Artificial Intelligence and Machine Learning
  • Blockchain and Cryptocurrency
  • Corporate
  • Corporate Governance
  • Digital Health
  • Emerging Companies and Venture Capital
  • Life Sciences
  • Mergers & Acquisitions
Recent Insights
Client Highlights
Wilson Sonsini Advises QuadSci on $8 Million Series A
On February 17, 2026, QuadSci, a predictive and prescriptive AI for customer intelligence, secured an $8 million Series A financing round led by Crosslink Capital, with participation from Alumni Ventures, Correlation Ventures, and angel investors Shail Jain, Peter Gibson, Tom Roloff, and Rob Eberle. Wilson Sonsini Goodrich & Rosati advised QuadSci on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Mews on $300 Million Series D Funding
On January 22, 2026, Mews, an operating system for hospitality, announced it has raised $300 million in a Series D funding round led by EQT Growth, with new investors Atomico, and HarbourVest Partners, and participation from existing investors Kinnevik, Battery Ventures, and Tiger Global. This latest funding values the company at $2.5 billion and is the largest funding round ever in hospitality software. Wilson Sonsini Goodrich & Rosati advised Mews on the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.